Axel Gerdtsson

697 total citations
21 papers, 294 citations indexed

About

Axel Gerdtsson is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Axel Gerdtsson has authored 21 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 10 papers in Pulmonary and Respiratory Medicine and 5 papers in Rheumatology. Recurrent topics in Axel Gerdtsson's work include Prostate Cancer Diagnosis and Treatment (8 papers), Testicular diseases and treatments (6 papers) and Prostate Cancer Treatment and Research (6 papers). Axel Gerdtsson is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (8 papers), Testicular diseases and treatments (6 papers) and Prostate Cancer Treatment and Research (6 papers). Axel Gerdtsson collaborates with scholars based in Sweden, United States and Norway. Axel Gerdtsson's co-authors include Andrew J. Vickers, David Ulmert, Hans Lilja, Jonas Manjer, Anders Bjartell, Peter T. Scardino, Anna M. Dahlin, Thomas Björk, Peter M. Nilsson and Daniel D. Sjoberg and has published in prestigious journals such as Journal of Clinical Oncology, BMJ and The Journal of Urology.

In The Last Decade

Axel Gerdtsson

18 papers receiving 288 citations

Peers

Countries citing papers authored by Axel Gerdtsson

Since Specialization

Citations

This map shows the geographic impact of Axel Gerdtsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Gerdtsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Gerdtsson more than expected).

Fields of papers citing papers by Axel Gerdtsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel Gerdtsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Gerdtsson. The network helps show where Axel Gerdtsson may publish in the future.

Co-authorship network of co-authors of Axel Gerdtsson

This figure shows the co-authorship network connecting the top 25 collaborators of Axel Gerdtsson. A scholar is included among the top collaborators of Axel Gerdtsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Gerdtsson. Axel Gerdtsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk of invasive penile cancer after treatment of penile intraepithelial neoplasia 2025 ·British Journal of Urology ·(unknown), Axel Gerdtsson, Christian Torbrand, (unknown)	1
2	The past, present and future of penile cancer in the Nordic countries. Results from NORDCAN 2025 ·BJUI Compass ·(unknown), Axel Gerdtsson, (unknown), (unknown), Peter Kirrander, Jakob Kristian Jakobsen	0
3	Post chemotherapy retroperitoneal lymph node dissection (PC-RPLND) for metastatic pure seminoma. 2024 ·Journal of Clinical Oncology ·Axel Heidenreich, Siamak Daneshmand, (unknown), (unknown), Pia Paffenholz, Alireza Ghoreifi, (unknown), Marcus Hentrich, (unknown), Peter Albers, Clint Cary, Axel Gerdtsson, Anders Kjellman, Helene F. S. Negaard	0
4	Initial surveillance in men with marker negative clinical stage IIA non‐seminomatous germ cell tumours 2024 ·British Journal of Urology ·Axel Gerdtsson, Helene F. S. Negaard, (unknown), (unknown), (unknown), Ingrid Glimelius, (unknown), Hege Sagstuen Haugnes, (unknown), (unknown), (unknown), Ása Karlsdóttir, Anders Kjellman, (unknown), (unknown), Rolf Wahlqvist, Olof Ståhl, Torgrim Tandstad	1
5	Violation of onco-surgical principles is associated with survival outcomes in upper tract urothelial carcinomas after radical nephroureterectomy 2024 ·Scandinavian Journal of Urology ·Ioannis Patras, (unknown), Axel Gerdtsson, (unknown), (unknown), (unknown), (unknown), (unknown), Johannes Bobjer, Fredrik Liedberg	1
6	Evaluation of data quality in the Swedish National Penile Cancer Register 2024 ·Scandinavian Journal of Urology ·(unknown), (unknown), Fredrik Sandin, Mats Lambe, Gediminas Baseckas, Axel Gerdtsson, Kimia Kohestani, Peter Kirrander	0
7	Location of Retroperitoneal Lymph Node Metastases in Upper Tract Urothelial Carcinoma: Results from a Prospective Lymph Node Mapping Study 2023 ·European Urology Open Science ·Johannes Bobjer, Axel Gerdtsson, (unknown), Gediminas Baseckas, (unknown), (unknown), (unknown), (unknown), Oskar Hagberg, Petter Kollberg, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Fredrik Liedberg	1
8	Validation of a prediction model for post‐chemotherapy fibrosis in nonseminoma patients 2023 ·British Journal of Urology ·Axel Gerdtsson, Gustav Torisson, (unknown), (unknown), (unknown), Ulf Håkansson, Magnus Törnblom, Helene F. S. Negaard, Ingrid Glimelius, (unknown), Ása Karlsdóttir, Hege Sagstuen Haugnes, (unknown), (unknown), Rolf Wahlqvist, Torgrim Tandstad, (unknown), Olof Ståhl, Anders Kjellman	2
9	Urosymphyseal fistula after pelvic radiotherapy in a tertial referral centre – a rare entity with significant comorbidity requiring multidisciplinary management 2023 ·Scandinavian Journal of Urology ·(unknown), (unknown), Gediminas Baseckas, Johannes Bobjer, Axel Gerdtsson, (unknown), Petter Kollberg, Marie‐Louise Lydrup, (unknown), (unknown), (unknown), Johan Tham, (unknown), Fredrik Liedberg	1
10	Primary retroperitoneal lymph node dissection (RPLND) in seminoma stage IIA-IIC ≤3cm: Combined results of the SWENOTECA (Swedish Norwegian Testicular Cancer Group) and Cologne. 2023 ·Journal of Clinical Oncology ·Torgrim Tandstad, Anders Kjellman, (unknown), (unknown), Gabriella Cohn‐Cedermark, Axel Gerdtsson, Ingrid Glimelius, (unknown), Hege Sagstuen Haugnes, (unknown), Ása Karlsdóttir, (unknown), Helene F. S. Negaard, David Pfister, Olof Ståhl, (unknown), (unknown), Axel Heidenreich, Pia Paffenholz, (unknown), (unknown)	4
11	MP33-04 THE EARLY RESULTS OF THE SWENOTECA (SWEDISH NORWEGIAN TESTICULAR CANCER GROUP) INTRODUCTION OF PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION (RPLND) IN SEMINOMA STAGE IIA-IIB ≤ 3cm 2023 ·The Journal of Urology ·(unknown), Axel Gerdtsson, (unknown), Dag S. Halvorsen, (unknown), (unknown), Ingrid Glimelius, Hege Sagstuen Haugnes, Ása Karlsdóttir, Olof Ståhl, (unknown), (unknown), Torgrim Tandstad, Anders Kjellman	1
12	Increasing rates of urinary and bloodstream infections following transrectal prostate biopsy in South Sweden 2022 ·British Journal of Urology ·Oskar Ljungquist, (unknown), Magnus Grabe, (unknown), Axel Gerdtsson, Gustav Torisson, Anders Bjartell, Kristian Riesbeck	2
13	Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group 2021 ·European Urology Oncology ·Axel Gerdtsson, (unknown), (unknown), (unknown), Ulf Håkansson, Magnus Törnblom, Helene F. S. Negaard, Ingrid Glimelius, (unknown), Ása Karlsdóttir, Hege Sagstuen Haugnes, (unknown), (unknown), (unknown), Rolf Wahlqvist, Torgrim Tandstad, Gabriella Cohn‐Cedermark, Olof Ståhl, Anders Kjellman	15
14	Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group 2019 ·European Urology Oncology ·Axel Gerdtsson, Ulf Håkansson, Magnus Törnblom, (unknown), Helene F. S. Negaard, Ingrid Glimelius, (unknown), Ása Karlsdóttir, Hege Sagstuen Haugnes, (unknown), (unknown), (unknown), Rolf Wahlqvist, Torgrim Tandstad, Gabriella Cohn‐Cedermark, Olof Ståhl, Anders Kjellman	36
15	Long-term prediction of prostate cancer diagnosis and death using PSA and obesity related anthropometrics at early middle age: data from the malmö preventive project 2017 ·Oncotarget ·Melissa Assel, Axel Gerdtsson, Daniel L.J. Thorek, Sigrid Carlsson, Johan Malm, Peter T. Scardino, Andrew J. Vickers, Hans Lilja, David Ulmert	2
16	Screening for Prostate Cancer Starting at Age 50–54 Years. A Population-based Cohort Study 2016 ·European Urology ·Sigrid Carlsson, Melissa Assel, David Ulmert, Axel Gerdtsson, Jonas Hugosson, Andrew J. Vickers, Hans Lilja	37
17	Anthropometric Measures at Multiple Times Throughout Life and Prostate Cancer Diagnosis, Metastasis, and Death 2015 ·European Urology ·Axel Gerdtsson, (unknown), Daniel L.J. Thorek, Lorelei A. Mucci, Michael J. Evans, Peter T. Scardino, Per-Anders Abrahamsson, Peter M. Nilsson, Jonas Manjer, Anders Bjartell, Johan Malm, Andrew J. Vickers, Stephen J. Freedland, Hans Lilja, David Ulmert	13
18	Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study 2013 ·BMJ ·Andrew J. Vickers, David Ulmert, Daniel D. Sjoberg, (unknown), Thomas Björk, Axel Gerdtsson, Jonas Manjer, Peter M. Nilsson, Anna M. Dahlin, Anders Bjartell, Peter T. Scardino, Hans Lilja	173
19	986 HOW SOON CAN WE IDENTIFY MEN AT HIGH RISK FOR PROSTATE CANCER DEATH? AN EARLY SURVEILLANCE STRATEGY FOR PROSTATE CANCER 2011 ·The Journal of Urology ·Andrew J. Vickers, Caroline Savage, Thomas Björk, Axel Gerdtsson, Jonas Manjer, Peter M. Nilsson, Anders Dahlin, Anders Bjartell, Peter T. Scardino, David Ulmert, Hans Lilja	1
20	Toward a rational strategy for prostate cancer screening based on long-term risk of prostate cancer metastases and death: Data from a large, unscreened, population-based cohort followed for up to 30 years. 2011 ·Journal of Clinical Oncology ·Hans Lilja, C. Savage, Axel Gerdtsson, Thomas Björk, Jonas Manjer, P.M. Nilsson, Anna M. Dahlin, Anders Bjartell, Peter T. Scardino, David Ulmert, Andrew J. Vickers	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact